The median number of liver lesions confirmed at the reference standard was higher in patients with a PSMA-PET positive for hepatic disease compared to patients with a PSMA-PET negative within the liver (median 4 vs. 1 metastasis, p = 0.013; Figure 3). Here, FOLH1 is linked to liver disorder.